As life span has increased among patients with cancer, survivorship has become an important component of breast cancer care. Among survivorship concerns, adequate contraceptive counseling is needed for premenopausal patients who are not seeking to become pregnant.
-
2022 (v1)PublicationUploaded on: February 13, 2024
-
2022 (v1)Publication
Background Higher consumption of coffee and tea has been associated with improved health outcomes in the general population and improved breast cancer (BC) prognosis. This study investigated patterns of coffee and tea consumption and association with patient-reported outcomes (PROs) and clinical outcomes among survivors of BC. Methods The...
Uploaded on: February 14, 2024 -
October 24, 2018 (v1)Journal article
HER2-negative metastatic breast cancer (MBC) is a common setting in which chemotherapy could be effective even in later lines of treatment. Oral etoposide has demonstrated clinical activity in this setting in small-scale studies, but its efficacy has not been compared to that of other chemotherapy regimens.
Uploaded on: December 4, 2022 -
April 2021 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
May 2016 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
May 20, 2021 (v1)Journal article
1064 Background: In 11.2018, the PIK3CA-inhibitor alpelisib was made available in France through an early access program (EAP), in combination with fulvestrant in pre-treated PIK3CA-mutant, HR-positive, HER2-negative advanced breast cancer (ABC) patients. Patients had to received two or more prior systemic treatments for ABC, including an...
Uploaded on: December 3, 2022 -
April 5, 2016 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
2023 (v1)Journal article
SOLAR-1 and BYLieve trials documented the efficacy of the PI3K-inhibitor alpelisib in pre-treated PIK3CA-mutant, hormone receptor-positive, HER2-negative (HR+/HER2-) advanced breast cancer (ABC) patients. We report here real-life data of patients prospectively registered in the French alpelisib early access program (EAP) opened to PIK3CA-mutant...
Uploaded on: October 11, 2023